menu close
www.medable.com
Medable Inc.-Logo

Medable Stock

Company Profile:

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies.

Sign up for SecondMarket™ to view the market and buy or sell Medable Stock
Buy + Sell

Medable Funding

Sign up to gain insights into Medable funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Sep 30, 2021 Series D 304.00M
Price
Valuation
Apr 05, 2021 Series C 78.00M
Price
Valuation
Oct 29, 2020 Series C 63.56M
Price
Valuation
Apr 13, 2020 Series C 25.66M
Price
Valuation
Jul 31, 2018 Series B 16.15M
Price
Valuation
Dec 16, 2016 Series A 436.00K
Price
Valuation
Dec 04, 2015 Series A 3.20M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Medable Management Team

  • Director

    David Hartwig

  • Co-Founder, Chief Technology Officer, Director

    Timothy Smith

  • Co-Founder, CEO, Director

    MIchelle Longmire

  • Director

    Richard Lim

  • Co-Founder, Chief Architect

    James Sas

  • Director

    Young Sohn

  • Co-Founder

    Perry Robinson

Medable Major Investors

  • Streamlined Ventures

  • GSR Ventures

  • PPD, Inc.

  • Obvious Ventures

  • PPD, Inc.

  • Sapphire Ventures LLC

  • Blackstone Group LP

  • Western Technology Investment (WTI)

  • Tiger Global Management LLC

Learn More About Medable Stock

Buy Medable Stock
01

Medable stock does not trade on public stock exchanges. Medable stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Medable stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Medable Stock
02

Medable Stock does not trade on public stock exchanges. In order to sell Medable shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Medable Stock Price
03

Medable does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Medable share price and other valuable private market data.

Read more about secondary market private company stock prices:

Medable Stock Ticker Symbol
04

There is no ticker symbol for Medable stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Medable Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Medable stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Medable Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Medable stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Medable Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Medable IPO
08

Medable is a private company and has not had an IPO. There is currently no Medable IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Medable IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Medable Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Solugen-Logo

Solugen

Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Generate Biomedicines-Logo

Generate Biomedicines

Generative biology company with a revolutionary approach to drug development.

Source: Nasdaq Private Market Tape D™